Active Ingredient(s): Sarecycline Hydrochloride
FDA Approved: * October 1, 2018
Pharm Company: * ALLERGAN INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Seysara Overview

Sarecycline is a narrow-spectrum tetracycline-derived antibiotic.[1][2] It is specifically designed for the treatment of acne, and was approved by the FDA in October 2018 for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.[3] Two randomized and well-controlled clinical trials reported efficacy data on both facial and truncal acne (back and chest).[4] Ef...

Read more Seysara Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Seysara Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sarecycline Hydrochloride
  • Tablet: 100mg, 150mg, 60mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Seysara: (6 results)

Sorted by National Drug Code
  • 0023-6245 Seysara 60 mg Oral Tablet by Allergan, Inc.
  • 0023-6246 Seysara 100 mg Oral Tablet by Allergan, Inc.
  • 0023-6247 Seysara 150 mg Oral Tablet by Allergan, Inc.
  • 16110-245 Seysara 60 mg Oral Tablet, Coated by Almirall, LLC
  • 16110-246 Seysara 100 mg Oral Tablet, Coated by Almirall, LLC
  • 16110-247 Seysara 150 mg Oral Tablet, Coated by Almirall, LLC

Other drugs which contain Sarecycline Hydrochloride or a similar ingredient: (1 result)